Vascular Graft Market Share Analysis of The Top Industry Players, Growth Opportunities & Country Level Segments
The global
vascular graft market is expected to witness significant growth due to
increasing prevalence of vascular disorders, growing aging population and
technological advancement in medical devices. Hemodialysis access graft,
endovascular stent graft and peripheral graft are the three-different type of
vascular grafts used for the treatment of various vascular disorders such as
high blood sugar and hypertension. Endovascular stent graft held the largest
share of the vascular graft market in 2017, due to their increasing demand in
minimally invasive surgeries.
On the basis of raw material, the vascular graft market is
categorized into polyester, polyurethane, polytetrafluorethylene and
biosynthetic materials. Polyester based grafts hold the largest share of the
market, due to high tensile strength, durability and easy availability of this
type of raw material. During the forecast period biosynthetic materials are
expected to witness significant growth owing to their bio compatibility and
increasing acceptance among patients.
Developing economies provide ample opportunities to the key
players present in the vascular graft market, due to increasing public and
private healthcare expenditure, insurance coverage across the urban and rural
areas and growing prevalence of chronic disorders in these economies. According
to a report published in the Journal of Vascular Medicine & Surgery in
2015, vascular graft infection is minimum during surgery compared to
traditional surgeries, which may cause high risk of sepsis and major bleeding.
This will further create new opportunities for the market players in emerging
economies.
Request to Get the Sample Pages at:
North America held the largest share of vascular graft
market in 2017, due to the increasing prevalence of chronic and lifestyle
associated diseases, developed government reimbursement policies and advanced
healthcare infrastructure. During the forecast period, the market is expected
to witness fastest growth in Asia-Pacific, led by the increasing penetration of
advanced medical devices due to the growing prevalence of chronic diseases,
spur in government support and initiatives for increasing awareness about these
diseases and advanced treatments, and continuously improving healthcare
infrastructure.
Key players in the vascular graft market are introducing new
advanced products and investing in research and development. In January 2017,
Terumo Corporation acquired Bolton Medical, a manufacturer of thoracic and
abdominal stent graft systems. The acquisition was aimed to strengthen the
Terumo Corporation’s vascular graft business in the U.S.
Some of the other players in the vascular graft industry
include Bard Peripheral Inc, LeMaitre Vascular Inc, Cook Medical Inc, Cardinal
Health Inc, W.L. Gore & Associates Inc, Japan Lifeline Co., Ltd, Medtronic
Plc, B. Braun Melsungen AG.
Comments
Post a Comment